OTCMKTS:ONPH Oncology Pharma (ONPH) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ONPH Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume213 shsAverage Volume2,970 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Oncology Pharma alerts: Email Address Ad DTIweirdest stock market marches onFor the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth. And he sure seems to be right! Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs. That’s why this headline called it the “Weirdest bull market”Graham is hosting a “tell all” workshop about his Apex Indicator here About Oncology Pharma Stock (OTCMKTS:ONPH)Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.Read More Ad DTIweirdest stock market marches onFor the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth. And he sure seems to be right! Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs. That’s why this headline called it the “Weirdest bull market”Graham is hosting a “tell all” workshop about his Apex Indicator here ONPH Stock News HeadlinesMay 18 at 1:33 AM | reuters.comEU regulator scraps approval for pregnancy drug over cancer riskMay 16 at 8:49 AM | msn.comAmerican Oncology Network GAAP EPS of -$1.22, revenue of $364.34MMay 12, 2024 | americanbankingnews.comOncology Pharma (OTCMKTS:ONPH) versus DocuSign (NASDAQ:DOCU) Head to Head ReviewMay 10, 2024 | msn.comEnding Oncology's Toxic Relationship With High Chemotherapy DosesMay 7, 2024 | msn.comThe FDA targets pharma’s grip on costly, toxic cancer drug dosagesMay 3, 2024 | news.yahoo.comCoach's death spotlights pharma's profit wins in chemo drug shortageMay 2, 2024 | marketwatch.comNovartis to Buy Mariana Oncology for Up to $1.75 Bln in Boost to Radioligand Therapy BusinessApril 30, 2024 | msn.comONO to acquire Deciphera Pharmaceuticals in $2.4B dealApril 30, 2024 | yahoo.comJapan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansionApril 29, 2024 | benzinga.comWhy Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?April 29, 2024 | msn.comDeciphera stock soars after Ono Pharmaceutical’s $2.4B buyout dealApril 23, 2024 | bizjournals.comPeninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kidsApril 17, 2024 | markets.businessinsider.comNika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary SupplementApril 12, 2024 | bloomberg.comNuclear Medicine Is Big Pharma’s New Target in Cancer RaceApril 10, 2024 | businesswire.comOnchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective TreatmentApril 9, 2024 | msn.comBoehringer Ingelheim Upbeat On China, Forms Cancer Drug PartnershipApril 4, 2024 | msn.comKintara and TuHURA enter merger deal to advance oncology pipelineApril 4, 2024 | msn.comCancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led roundApril 4, 2024 | msn.comA new hope in immunotherapy against cancerMarch 26, 2024 | msn.comRegeneron's blood cancer therapy faces setback as FDA raises trial concernsMarch 25, 2024 | msn.comUS FDA declines to approve Regeneron's blood cancer therapyMarch 21, 2024 | bizjournals.comClinical trial results show new Penn technology could be the key to fighting brain cancerMarch 12, 2024 | msn.comAbilityPharma receives funds to advance pancreatic cancer trialMarch 4, 2024 | msn.comIovance stock rises after FDA lifts clinical hold on lung cancer trialFebruary 27, 2024 | benzinga.comOncology Pharma Stock (OTC:ONPH) Dividends: History, Yield and DatesSee More Headlines Receive ONPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/18/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Prepackaged software Sub-IndustryN/A Current SymbolOTCMKTS:ONPH CUSIPN/A CIKN/A Webwww.oncology-pharma.com Phone(415) 869-1038Fax858-385-8997Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares38,660,000Free Float31,704,000Market Cap$4,000.00 OptionableNot Optionable Beta-0.75 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Chuck WagnerPresident, Treasurer & ChairmanMr. George MalesekInterim Chief Executive OfficerMr. Dimitri Theofilopolous Esq.Legal CounselKey Competitors180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFF3SBioOTCMKTS:TRSBF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFView All Competitors ONPH Stock Analysis - Frequently Asked Questions How do I buy shares of Oncology Pharma? Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ONPH) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncology Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.